| Efficacy and Safety of Oral BT-11 in Ulcerative Colitis (NCT03861143) | NImmune Biopharma | 2019-08-14 |
| Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis (NCT03977480) | Tianjin Hemay Pharmaceutical Co., Ltd | 2019-08-13 |
| Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis (NCT03760003) | Abivax S.A. | 2019-08-13 |
| Aquamin® as an Adjuvant Intervention for Ulcerative Colitis (NCT03869905) | Muhammad N Aslam, MD | 2019-08-08 |
| Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Ulcerative Colitis (NCT04029649) | Fakultas Kedokteran Universitas Indonesia | 2019-08-01 |
| Inflammatory Bowel Diseases Remission Registry (NCT04912999) | Tel-Aviv Sourasky Medical Center | 2019-08-01 |
| Fecal Transplant for Ulcerative Colitis (NCT03948919) | University of Minnesota | 2019-07-31 |
| Antimicrobial Therapy for Ulcerative Colitis (UC) (NCT03986996) | Wolfson Medical Center | 2019-07-25 |
| Comparative Effectiveness of Biologics or Small Molecule Therapies in Inflammatory Bowel Disease (IBD) (NCT04852666) | University of North Carolina, Chapel Hill | 2019-07-25 |
| Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO (NCT03816345) | National Cancer Institute (NCI) | 2019-07-16 |
| Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS (NCT04018599) | Fresenius Kabi SwissBioSim GmbH | 2019-07-15 |
| Safety and Efficacy of Fecal Microbiota Transplantation (NCT04014413) | Chinese University of Hong Kong | 2019-07-15 |
| Special Physical Exercises as a Therapeutic Intervention for Inflammatory Bowel Disease (NCT04303260) | Tel-Aviv Sourasky Medical Center | 2019-07-08 |
| Faecal Microbiota Transplantation in the Treatment of Chronic Pouchitis (NCT04100291) | Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery | 2019-07-01 |
| Investigation of the Faecal Loss of Vedolizumab and Its Role in Influencing Serum Drug Levels, Outcomes and Response in Ulcerative Colitis (NCT04006080) | Guy's and St Thomas' NHS Foundation Trust | 2019-07-01 |
| Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis (NCT03934216) | Bristol-Myers Squibb | 2019-07-01 |
| Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease (NCT03656627) | Alliance Foundation Trials, LLC. | 2019-06-27 |
| Russian Extremely Severe Ulcerative Colitis Study (NCT03947931) | State Scientific Centre of Coloproctology, Russian Federation | 2019-06-20 |
| Progression of Damage in Ulcerative Colitis (NCT03955328) | David Garcia Cinca | 2019-06-15 |
| Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis (NCT03945188) | Arena Pharmaceuticals | 2019-06-13 |
| Cell Surface Marker Expression in Autoimmune Diseases (NCT03757065) | Alpine Immune Sciences, Inc. | 2019-06-12 |
| Impact of Additional Treatment With Saccharomyces Boulardii on Quality of Life in Patients With Mild Forms of Ulcerative Colitis and Crohn Disease (NCT03941418) | University Clinic Dr Dragisa Misovic-Dedinje | 2019-06-01 |
| Development and Validation of a Deep Learning Algorithm to Evaluate Endoscopic Disease Activity of Ulcerative Colitis. (NCT03973437) | Shandong University | 2019-06-01 |
| Dynamic Changes of Gut Microbiota in UC After FMT (NCT03949257) | The Second Hospital of Nanjing Medical University | 2019-06-01 |
| HF2 Therapy in the Treatment of Active Ulcerative Colitis (NCT03720002) | Sheba Medical Center | 2019-05-29 |
| Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab (NCT03798691) | University of Wisconsin, Madison | 2019-05-28 |
| Vegetarian Diet in IBD (NCT04018040) | Edith Cowan University | 2019-05-06 |
| GB004 in Adult Subjects With Active Ulcerative Colitis (NCT03860896) | GB004, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | 2019-04-24 |
| Efficacy and Safety of BBT-401-1S in Ulcerative Colitis (NCT03800420) | Bridge Biotherapeutics, Inc. | 2019-04-22 |
| A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis. (NCT03675477) | Reistone Biopharma Company Limited | 2019-04-13 |
| High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-standing Inflammatory Bowel Disease (IBD) (NCT04191655) | Beth Israel Deaconess Medical Center | 2019-04-03 |
| Efficacy and Safety of Modified Gegen Qinlian Decoction for Ulcerative Colitis With Damp-heat Syndrome (NCT04057547) | Xiyuan Hospital of China Academy of Chinese Medical Sciences | 2019-04-01 |
| Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative Colitis (NCT04000139) | University of Zurich | 2019-04-01 |
| SAD/MAD Study in Healthy Subjects and Adults With UC to Evaluate Safety, Tolerability, PK, PD of AMT-101 (NCT04224857) | Applied Molecular Transport | 2019-04-01 |
| Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis (NCT03794765) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2019-04-01 |
| Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis) (NCT03884439) | Pfizer | 2019-03-18 |
| Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis (NCT03768219) | Aptevo Therapeutics | 2019-03-18 |
| Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative Colitis (NCT03724929) | Centre Hospitalier Universitaire de Saint Etienne | 2019-03-04 |
| Development and Validation of a Self-reported Objective Index of Work Disability in Inflammatory Bowel Disease (NCT03872726) | Corporacion Parc Tauli | 2019-03-01 |
| Golimumab Trough Levels in Patients With Ulcerative Colitis (NCT03773445) | Hospital San Carlos, Madrid | 2019-03-01 |
| Advanced Therapy Registry of IBD Patients (NCT04998084) | Tel-Aviv Sourasky Medical Center | 2019-02-28 |
| Sonographic Assessment in Severe Ulcerative Colitis Patients Admitted for Intravenous Corticosteroids and Eligible for Infliximab Rescue Therapy; a Prospective Clinician-blinded Observational Study Protocol. (NCT03942861) | Copenhagen University Hospital at Herlev | 2019-02-21 |
| Transcutaneous VNS to Treat Pediatric IBD (NCT03863704) | Northwell Health | 2019-02-14 |
| Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in Patients With Ulcerative Colitis (UC) (NCT03832400) | NuBiyota | 2019-02-04 |
| Special Drug-Use Surveillance Study on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis] (NCT03824561) | Takeda | 2019-02-01 |
| The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study (NCT03835780) | Momentum Data | 2019-02-01 |
| Healthcare Resource Utilisation, Common Mental Health Problems, and Infections in People With Inflammatory Bowel Disease (NCT03836612) | Momentum Data | 2019-02-01 |
| Subjective Near-infrared Fluorescence Guidance in Perfusion Assessment of Ileal Pouch Formation and Ileal-pouch-anal Anastomosis (NCT04695184) | Charite University, Berlin, Germany | 2019-02-01 |
| Objective Perfusion Rate Assessment by Near-infrared Fluorescence in Ileal Pouch Formation and Ileal-pouch-anal Anastomosis (NCT04695964) | Charite University, Berlin, Germany | 2019-02-01 |
| A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Relapse in Patients With IBD (NCT04079335) | Chinese University of Hong Kong | 2019-01-28 |
| Fecal Microbiota Transplantation for Ulcerative Colitis (NCT03804931) | Guangzhou First People's Hospital | 2019-01-20 |
| TUDCA as a Therapy for Ulcerative Colitis (UC) (NCT04114292) | Washington University School of Medicine | 2019-01-17 |
| Endoscopic Ultrasound Determines Disease Activity in Crohn's Disease And Ulcerative Colitis (NCT03863886) | Carilion Clinic | 2019-01-04 |
| EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis (NCT03679546) | Rennes University Hospital | 2019-01-04 |
| Reactive vs. Proactive Pain Control in IBD (NCT03798405) | Cedars-Sinai Medical Center | 2019-01-01 |
| A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis (NCT03759041) | Seres Therapeutics, Inc. | 2018-12-19 |
| 5-HTP in Patients With IBD in Clinical and Biologic Remission:Effect on Fatigue Scores (NCT03574948) | University Hospital, Ghent | 2018-12-06 |
| Identify Predictors That Distinguish Between Tofacitinib Responders and Non-responders Based on Genotype and Cellular and Molecular Profiles From Pinch Biopsies, Blood and Stool Samples (NCT03663400) | NYU Langone Health | 2018-12-04 |
| Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel Disease (NCT03239704) | Mount Sinai Hospital, Canada | 2018-12-01 |
| Outcomes Mandate National Integration With Cannabis as Medicine (NCT03944447) | OMNI Medical Services, LLC | 2018-12-01 |
| Flaxseed Lignan-Enriched Complex (FLC) for the Treatment of Patients With Ulcerative Colitis (UC): A Pilot Assessment (NCT02201758) | University of Saskatchewan | 2018-12-01 |
| Pro-active Fecal Calprotectin Monitoring PROMOTE-UC (NCT03549988) | University of British Columbia | 2018-12-01 |
| Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study (NCT03772145) | University of North Carolina, Chapel Hill | 2018-11-27 |
| Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs (NCT03729674) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2018-11-26 |
| Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC) (NCT03669822) | Johns Hopkins University | 2018-11-10 |
| Short Versus Long Interval to Ileostomy Reversal After Ileal Pouch Surgery (NCT03587519) | University of Colorado, Denver | 2018-11-06 |
| Electrical Vagal Nerve Stimulation in Ulcerative Colitis (NCT03908073) | Queen Mary University of London | 2018-10-30 |
| A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC) (NCT03558152) | Genentech, Inc. | 2018-10-26 |
| A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (NCT03524092) | Eli Lilly and Company | 2018-10-19 |
| The Role of PET/MRI in the Diagnosis and Treatment of Children and Adolescents With Inflammatory Bowel Diseases (NCT03640637) | Odense University Hospital | 2018-10-18 |
| Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis (NCT02921555) | Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa | 2018-10-11 |
| Impact of Fecal Microbiota Transplantation in Ulcerative Colitis (NCT03483246) | Assistance Publique - Hôpitaux de Paris | 2018-09-17 |
| Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients (NCT03452501) | Hikma Pharmaceuticals LLC | 2018-08-26 |
| Diagnostic Validity of [18F]FSPG PET for the Assessment of Disease Activity in Inflammatory Bowel Disease (NCT03546868) | Asan Foundation | 2018-08-14 |
| Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis (NCT03616821) | AstraZeneca | 2018-08-07 |
| Capsulized Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis Patients (NCT03582969) | Assaf-Harofeh Medical Center | 2018-08-01 |
| Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) (NCT03196427) | Takeda | 2018-07-30 |
| A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) (NCT03519945) | Eli Lilly and Company | 2018-07-18 |
| Diet Treatment of Patients With Ulcerative Colitis in Remission (NCT02469220) | Regionshospital Nordjylland | 2018-07-01 |
| Safety and Efficacy of PBF-677 in Ulcerative Colitis Patients (NCT03773952) | Palobiofarma SL | 2018-07-01 |
| An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) (NCT03518086) | Eli Lilly and Company | 2018-06-18 |
| Clinical Database of Colorectal Robotic Surgery (NCT04013152) | Institut du Cancer de Montpellier - Val d'Aurelle | 2018-06-13 |
| Xeljanz Special Investigation for Long-term Use in UC Patients (NCT03643211) | Pfizer | 2018-06-08 |
| COLISURG : Exploratory Analysis of Sexual Function and the Impact of Biotherapies on Postoperative Morbidity. (NCT03504930) | Hospices Civils de Lyon | 2018-06-07 |
| Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy (NCT03359642) | University Hospital, Bordeaux | 2018-06-05 |
| FMT in Inflammatory Bowel Disease (NCT03477032) | St Vincent's Hospital Melbourne | 2018-06-01 |
| Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease (NCT04775732) | Imelda GI Clinical Research Center | 2018-06-01 |
| Fecal Microbiota Transplantation for Health Improvement (TFM3) (NCT04011943) | Federal Research and Clinical Center of Physical-Chemical Medicine | 2018-05-21 |
| A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditis (NCT03521232) | Entero Therapeutics | 2018-05-15 |
| Fecal Microbiota Transplantation for Chronic Pouchitis (NCT03538366) | Aalborg University Hospital | 2018-05-15 |
| Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UC (NCT03298022) | AltruBio Inc. | 2018-05-04 |
| Immunonutrition in Ulcerative Colitis (NCT03594708) | Baptist Memorial Health Care Corporation | 2018-04-30 |
| Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery (NCT03455751) | The Cleveland Clinic | 2018-04-17 |
| Infliximab Accelerated Induction in Moderate to Severe Pediatric UC (NCT03209232) | Schneider Children's Medical Center, Israel | 2018-04-16 |
| TAMIS-IPAA vs. Lap-IPAA for Ulcerative Colitiis (NCT03536988) | Jinling Hospital, China | 2018-04-12 |
| Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease (NCT03301311) | Children's Hospital Medical Center, Cincinnati | 2018-04-10 |
| An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis (NCT03290781) | Shire | 2018-04-04 |
| Gut Microbiome in Inflammatory Bowel Disease (NCT03589183) | Kyunghee University Medical Center | 2018-04-01 |
| A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's Disease (NCT03478956) | Hoffmann-La Roche | 2018-03-27 |
| First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Volunteers (NCT03482648) | Bridge Biotherapeutics, Inc. | 2018-03-20 |